PLYMOUTH MEETING, Pa., June 7 /PRNewswire/ -- InfaCare Pharmaceutical, a privately held, pediatric-focused specialty pharmaceutical company, announced today the formation of a New Product Advisory Board to counsel it in its drug development efforts. This world-class advisory group will assist the company in finalizing its drug development strategy, improving the likelihood innovative treatments will become available to address unmet needs of infants and older children.